Update on the management of invasive bladder cancer 2012.

about

Outcome of Mainz II Pouch Urinary Diversion after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer: Our Experience.

P2860

Q52719951-5769BEC6-40DB-40CA-8171-341601A6F815

P2860

Update on the management of invasive bladder cancer 2012.

Item

http://www.wikidata.org/entity/Q36171243

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Update on the management of invasive bladder cancer 2012.

@ast

Update on the management of invasive bladder cancer 2012.

@en

type

Item

label

Update on the management of invasive bladder cancer 2012.

@ast

Update on the management of invasive bladder cancer 2012.

@en

prefLabel

Update on the management of invasive bladder cancer 2012.

@ast

Update on the management of invasive bladder cancer 2012.

@en

P1476

Update on the management of invasive bladder cancer 2012.

@en

P2093

Hans Goethuys

http://www.w3.org/2001/XMLSchema#string

Hein Van Poppel

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Is orthotopic bladder replacement the new gold standard? Evidence from a systematic review.

Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction.

Perioperative chemotherapy for bladder cancer.

Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival.

The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.

P304

177-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S30850

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22904639

http://www.w3.org/2001/XMLSchema#string

P932

3421465

http://www.w3.org/2001/XMLSchema#string

Update on the management of invasive bladder cancer 2012.

about

P2860

P2860

Update on the management of invasive bladder cancer 2012.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932